Solid Biosciences Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $0 | $-14.1M | $-12.8M |
| Jun 2017 | $0 | $-11.9M | $-11.3M |
| Sep 2017 | $0 | $-13.7M | $-13.5M |
| Dec 2017 | $0 | $-15.2M | $-14.5M |
| Mar 2018 | $0 | $-16.0M | $-15.9M |
| Jun 2018 | $0 | $-18.2M | $-18.0M |
| Sep 2018 | $0 | $-19.2M | $-19.0M |
| Dec 2018 | $0 | $-22.4M | $-21.9M |
| Mar 2019 | $0 | $-30.3M | $-29.6M |
| Jun 2019 | $0 | $-27.0M | $-26.5M |
| Sep 2019 | $0 | $-29.7M | $-29.3M |
| Dec 2019 | $0 | $-32.3M | $-31.9M |
| Mar 2020 | $0 | $-26.9M | $-26.7M |
| Jun 2020 | $0 | $-19.0M | $-19.0M |
| Sep 2020 | $0 | $-21.2M | $-21.2M |
| Mar 2021 | — | $-16.9M | $-16.9M |
| Jun 2021 | — | $-18.7M | $-18.7M |
| Sep 2021 | — | $-18.0M | $-18.0M |
| Mar 2022 | — | $-25.4M | $-25.3M |
| Jun 2022 | — | $-25.4M | $-25.1M |
| Sep 2022 | — | $-21.1M | $-20.4M |
| Mar 2023 | — | $-32.0M | $-30.1M |
| Jun 2023 | — | $-26.8M | $-24.6M |
| Sep 2023 | — | $-23.1M | $-21.0M |
| Mar 2024 | — | $-26.9M | $-24.3M |
| Jun 2024 | — | $-27.8M | $-25.1M |
| Sep 2024 | — | $-35.2M | $-32.7M |
| Mar 2025 | — | $-40.1M | $-39.3M |
| Jun 2025 | — | $-41.7M | $-39.5M |
| Sep 2025 | — | $-48.1M | $-45.8M |
| Mar 2026 | — | $-57.3M | $-56.7M |
| Jun 2026 | — | $-57.4M | $-54.8M |